An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy
NCT00226811
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
78
Enrollment
INDUSTRY
Sponsor class
Conditions
Stomach Neoplasms
Interventions
DRUG:
Sunitinib
Sponsor
Pfizer